As we move forward into 2025, the pharmaceutical, biotechnology, and medical device industries continue to witness unparalleled growth, much of which is propelled by the groundbreaking work of Contract Research Organizations (CROs). These entities ar ...
Simon Corman has over 20 years of experience as a cutting-edge leader in clinical research. His strengths revolve around corporate and business development- with an ability to create strategic partnerships with various CROs and Sponsors and form publ ...
Abstract Good Clinical Practice (GCP) is an international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials. It also serves to protect the r ...
Clinical Research would be a lot more difficult without the help of Clinical Research Organizations (CROs). These companies within the pharmaceutical industry not only help support drug companies but also companies in the biotechnology and medical de ...
GAMES, PANAMA HATS, COFFEE, CHOCOLATE & CLINICAL RESEARCH DIVERSITY AT DIA 2017 From June 19th to the 21st FOMAT Medical Research hosted booth #958 at the DIA Meeting 2017 in Chicago, IL. FOMAT Medical Research is always looking for ways to inn ...
Carla Geovanna RodrÃguez Proaño is an Ecuadorian Biotechnology Engineer, who also obtained a master's degree in Forensic Science, from King’s College in London. She has been conducting clinical research with FOMAT Medical Research since last year and ...
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report state ...
FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by conc ...
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pan ...